about
Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapyAldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction.Incidence, etiology and predictors of adverse outcomes in 43,315 patients presenting to the Emergency Department with syncope: an international meta-analysis.Menopause and cardiovascular risk.Endothelial-dependent vasodilation and incidence of type 2 diabetes in a population of healthy postmenopausal women.New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.Assessing coronary heart disease in women.Coronary artery disease: clinical presentation, diagnosis and prognosis in women.Gender-specific aspects in the clinical presentation of cardiovascular disease.Hypertension alone or related to the metabolic syndrome in postmenopausal women.Indexed left atrial volume predicts the recurrence of non-valvular atrial fibrillation after successful cardioversion.Hypertension in postmenopausal women: pathophysiology and treatment.Are propensity scores really superior to standard multivariable analysis?Right versus left radial artery access for coronary procedures: an international collaborative systematic review and meta-analysis including 5 randomized trials and 3210 patients.TIMI, GRACE and alternative risk scores in Acute Coronary Syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients.Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses.Prevalence and non-invasive predictors of left main or three-vessel coronary disease: evidence from a collaborative international meta-analysis including 22 740 patients.Healthy diet to prevent cardiovascular diseases and osteoporosis: the experience of the 'ProSa' project.Remote ischaemic preconditioning in coronary artery bypass surgery: a meta-analysis.Use and misuse of multivariable approaches in interventional cardiology studies on drug-eluting stents: a systematic review.Hypertension in postmenopausal women: how to approach hypertension in menopause.Effects of pregnancy on endothelial function and cardiovascular disease risk in HIV-infected women.Progression of coronary artery calcium in men affected by human immunodeficiency virus infection.Epicardial adipose tissue is an independent marker of cardiovascular risk in HIV-infected patients.Human immunodeficiency virus infection is associated with accelerated atherosclerosis.Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects.Coronary aging in HIV-infected patients.Parallel increase of subclinical atherosclerosis and epicardial adipose tissue in patients with HIV.Prevalence of 'borderline' values of cardiovascular risk factors in the clinical practice of general medicine in Italy: results of the BORDERLINE study.Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women.Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women.Coronary atherosclerosis in outlier subjects at the opposite extremes of traditional risk factors: Rationale and preliminary results of the Coronary Atherosclerosis in outlier subjects: Protective and novel Individual Risk factors Evaluation (CAPIREA randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study.SPIRIT Women, evaluation of the safety and efficacy of the XIENCE V everolimus-eluting stent system in female patients: referral time for coronary intervention and 2-year clinical outcomes.Novel insights on HIV/AIDS and cardiac disease: shedding light on the HAART of Darkness.Age and heart transplantation: results from a heart failure management unit.Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study.Atenolol in dilated cardiomyopathy: a clinical instrumental study.Acute myocardial infarction--from territory to definitive treatment in an Italian province.Subclinical coronary artery atherosclerosis in patients with erectile dysfunction.
P50
Q27008328-9FD35D0F-AB64-4FAF-A60E-B3D096BB0737Q31795978-2E4452BA-FA06-4548-BD7F-140E6A47D0A2Q33160800-8EBBB271-9FAE-4954-9345-E33511FF7FC1Q35298030-A9DB5397-50B3-4889-8EB5-CD3ABDC90410Q36056443-456646A3-5EB7-4A37-BB0C-93CE5B989FF1Q36166702-B2AAC57C-EC19-496E-B9A3-ADB07E965A77Q37387875-7BC9848E-5878-432F-A280-AFFB7CE50555Q37768979-EC42A1D9-37C6-4EA4-8100-219EDADF8DC0Q37788778-6AE2574B-B59B-44DB-9E9D-864302F5E65AQ37810907-DCCA9EBF-38D0-4D8B-AA01-3AEB1693414DQ37819621-3C200CF6-9A16-45DC-8434-A5101804D125Q37879655-51F992E5-8AA3-4B1F-A6EE-52B1FAD636C6Q37880361-06DDFB25-8658-4A74-8E4A-AFB95AD3366EQ37970804-C8C73280-3F0B-4C41-9D18-12AF73E0B35BQ37977758-21D15682-E08D-4D7A-A763-C2E060B3BDD0Q37987647-A00FEB17-4FDD-47DF-B932-766EF58F4BA7Q38012933-E355069D-215A-490C-BEC1-4DA3498F8D70Q38032324-60ED3559-36A0-435E-9F39-9EDC17C2BC13Q38033139-E053A913-CE42-40D7-BE9E-60F8B65401A9Q38033691-B14368ED-5B46-424D-ABF7-F123A98B446BQ38213829-D0BECAE3-B6BD-4F3F-BE97-568971B1D1ECQ38536488-597378E6-54C2-46BC-B690-EC3C1F308438Q39035129-BA134F45-66BD-4E79-9976-F0844B4EB5ECQ39035137-EB42F439-7311-4A3A-87AC-C07D5E2755E9Q39035141-9C449181-12AD-4665-9AF5-FAF9E13C0DEDQ39035145-0BB61505-F6BF-4223-ADB1-7F14F6BF8B45Q39035151-4044A214-EE86-4B2F-B148-D54A20A4291FQ39633398-1AFCE84F-B672-4621-B2D5-28EFCF5F70A6Q39722466-8D5A4422-3B90-44E2-AE32-EC1E804E31DEQ40115916-6B06D9E1-1FED-4895-998B-F9DA6B58D2C6Q40475136-0E39834C-9819-4C2A-8E07-F8E10A335352Q40884728-3D95B566-8F71-44A9-BFB6-B6D96F0AC002Q41347740-39730E9F-945A-4090-9FBF-4EAAB3DE3EAFQ42660489-EE0C4F1E-68AF-4445-93D7-FE2A9D1E78F5Q43163644-2CAA331D-BF14-429F-B483-4DFD75F76798Q43464918-73587984-144A-43AE-A1E2-F957EC52D9A2Q43513756-AD12E0FB-DC4E-4A02-A5B7-2D4ADD539378Q43526118-13097103-34E8-4126-983A-73AFCEE0A411Q43614764-0623D32C-36A1-43F1-AE0A-DF6957D9B28AQ43807766-9CBEA9CE-F66D-4480-AA73-9A47DF8BAE30
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Maria Grazia Modena
@ast
Maria Grazia Modena
@en
Maria Grazia Modena
@es
Maria Grazia Modena
@nl
Maria Grazia Modena
@sl
type
label
Maria Grazia Modena
@ast
Maria Grazia Modena
@en
Maria Grazia Modena
@es
Maria Grazia Modena
@nl
Maria Grazia Modena
@sl
prefLabel
Maria Grazia Modena
@ast
Maria Grazia Modena
@en
Maria Grazia Modena
@es
Maria Grazia Modena
@nl
Maria Grazia Modena
@sl
P214
P1053
N-2442-2015
P106
P1153
7005619508
P21
P214
P31
P3829
P396
IT\ICCU\SBLV\268495
P496
0000-0002-4704-4663
P569
1962-01-01T00:00:00Z
P734
P735
P7859
viaf-90345606